Clinical Research Associates (CRAs) are integral members of Integrium’s clinical trial study teams. These professionals are highly trained team members who can effectively interact with investigators and site coordinators to get the necessary results. We understand the importance of not spreading our CRAs too thin across studies, so they can better devote their time and attention to facilitating rapid enrollment and proper documentation, as well as to strict adherence to GCP/ICH guidelines. We locate our CRAs geographically in order to be most cost-effective for our sponsors.

Because Integrium specializes in cardiovascular and metabolic disease trials, our CRAs draw from similar experience when conducting new trials in these therapeutic indications — which means they dedicate their efforts to the investigator site, not to time spent negotiating a learning curve. We have proven standard operating procedures (SOPs) that ensure consistency across the entire study and between CRAs.

Our experienced CRAs also have an understanding of the scientific rationale behind the therapeutics in development, so they can stay attuned to the bigger picture while managing the day-to-day details at sites. This expertise has resulted in valued relationships between our CRAs and investigators across Integrium’s dynamic network of clinical research sites. Experience tells us that a good relationship with a clinical investigator can make all the difference when addressing challenges in a trial.

Integrium is proud to have such capable and passionate individuals monitoring trials on behalf of our clients. Our low CRA turnover rate is a testament to the fact that our CRAs are not only dedicated to their projects, but also to Integrium and our focus on cardiovascular and metabolic disease research.